A vascular connection to Alzheimer's disease

Microcirculation

Volumn 8, Issue 4, 2001, Pages 207-220

  Rhodin, Johannes A ^a   Thomas, Tom ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Woodlands Med and Research Center   (United States)

Author keywords

Alzheimer's disease (AD); Amyloid ; Antioxidants; Cytokine blockers; Electron microscopic analysis; Endothelium; Estrogen; Inflammation; Leukocyte transmigration; Microcirculation; Selective estrogen receptor modulator (SERM); Ultravital video recording

Indexed keywords

ANIMALIA;

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL; DRUG EFFECT; HUMAN; INFLAMMATION; METABOLISM; MICROCIRCULATION; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; MICROCIRCULATION;

EID: 0035434790     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mn.7800086     Document Type: Review

References (64)

1. Aoyama K, Matsubara K, Fujikawa Y, Nagahiro Y, Shimizu K, Umegae N, Hayase N, Shiono H, Kabayashi S. (2000). Nitration of manganese Superoxide dismutase in cerebrospinal fluids is a marker for peroxinitrite-mediated oxidauve stress in neurodegenerative diseases. Ann Neural 47:524-527.
2. Bush AL, Martins RN, Rumble B, Moir R, Fuller S, Milward E, Currie J, Ames D, Weidemann A, Fischer P, Multhaup G, Beyreuther K, Masters LL. (1990). The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem 265: 15977-15983.
3. Chabrier P-E, Demerlé-Pallardy C, Auguet M. (1999). Nitric oxide synthases: targets for therapeutic strategies in neurological diseases. Cell Mol Life Sci 55:1029-1035.
4. Chambers R. Zweifach BW. (1944). The topography and function of mesenteric capillary circulation. Am J Anat 75: 173-205.
5. Chen M, Inestrosa NC, Ross GS, Fernandez FIL. (1995). Platelets are the primary resource of amyloid beta-peptide in human blood. Biochem Biophys Res Commun 218:96-103.
6. Davies TA, Billingslea A, Johnson R, Greenberg S, Ortiz M, Long H, Sgro K, Tibbles H, Seetoo K, Rathbun W, Schonhorn J, Rimons ER. (1997). Stimulus responses and amyloid precursor protein processing in DAMI megakaryocytes. J Lab Clin Med 130:21-32.
7. de la Torre JC. (1994). Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci Biobehav Rev 18:397-401.
8. de la Torre JL, Hachinski V. (Eds.) (1997). Cerebrovascular pathology in Alzheimer's disease. Ann NY Acad Sci 826:1-523.
9. de la Torre JC, Mussivand T. (1993). Can disturbed brain circulation cause Alzheimer's disease? Neurol Res 15:146-153.
10. Frangione B. (1989). Systemic and cerebral amyloidosis. Ann Med 21:69-72.
11. Frasher WG Jr. (1973). Attached floating cat mesentery preparation for vital microscopy. Microvasc Res 5:376-383.
12. Hensley K, Maidt ML., Yu Z, Sang H, Markesbery WR, Floyd RA. (1988). Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 18:8126-8132.
13. Jancso G, Domoki F, Santha P, Varga J, Fischer J, Orosz K, Penke B, Becskei A, Dux M, Toth L. (1998). β-Amyloid (1-42) peptide impairs blood-brain barrier function after intracarotid infusion in rats. Neurosci Lett 253:139-141.
14. H. Kalaria RN. (1993). Cerebral microvasculature and immunological factors in Alzheimer's disease. Clin Neurosci 1:204-211.
15. Kalaria RN. (1996). Cerebral vessels in ageing and Alzheimer's disease. Phartnacol Ther 72:193-214.
16. Kalaria RN. (1999). The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann NY Acad Sci 893:113-125.
17. Kalaria RN, Hedera P. (1995). Differential degeneration of the cerebral microvasculature in Alzheimer's disease. NeuroReport 6:477-480.
18. Kalaria RN, Hedera P. (1996). β-amyloid vasoactivity in Alzheimer's disease. Lancet 347:1492-1493.
19. Kalaria RN, Ince P. (Eds.) (2000). Vascular factors in Alzheimer s disease. Ann NY Acad Sci 903:1-556.
20. Kang J, Lemaire H, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K. Multhaup K. Beyreuther K, Muller-Hill B. (1987). The precursor of 'Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733-736.
21. Knopman D, Boland LL, Mosley T, Howard G. Liao D, Szoklo M, McGovern P, Folsom AR. (2001). Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 56:42-48.
22. Mattson MP, Rydel RR. (1996). Amyloid ox-tox transducers. Nature 382:674-675.
23. Mayrovitz HN, Tuma RF, Wiedemann MP. (1980). Leukocyte adherence in arterioles following extra vascular tissue trauma. Microvasc Res 20:264-272.
24. Miyakawa T, Kimura T, Hirata S, Fujise N, Ono T, Ishizuka K, Nakabayashi J. (2000). Role of blood vessels in producing pathological changes in the brain with Alzheimer's disease. Ann NY Acad Sci 903:46-54.
25. Naslund J, Haroutunian V, Mohs R, Davis KL, Davies P., Greengard P, Buxbaum JD. (2000). Correlation between elevated levels of amyloid-β peptide in the brain and cognitive decline. JAMA 283:1571-1577.
26. Ohkura T, Isse K. Akazawa K, Hamamoto M, Yaoi Y, Hagino N. (1994). Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr J 41:361-367.
27. Paris D, Parker TA, Town T, Suo Z, Fang C, Humphrey J, Crawford F, Mullan M. (1998). Role of peroxynitrite in the vasoactive and cytotoxic effects of Alzheimer's β-amyloid 1-40 peptide. Exp Neurol 152:116-122.
28. Perlmutter LS, Chang Chui H. (1990). Microangiopattiy, the vascular basement membrane and Alzheimer's disease: a review. Brain Res Bull 24:677-686.
29. Petito CK, Levy DK. (1980). The importance of cerebral arterioles in alterations of the blood-brain barrier. Lab Inn-st 43:262-268.
30. Rhodin JAG. (1986). Perfusion and supervision fixation effects on rat mesentery microvascular beds. Intravital and electron microscope analyses. J Submicrosc Cyto Palhol 18:453-470.
31. Rhodin JAG, Lim SS. (1979). Combined intravital microscopy and electron microscopy of the blind beginnings of the mesentcric lymphatic capillaries of the rat mesentery. Acta Physiol Scand Suppl 463:51-58.
32. Rhodin J, Thomas T, Bryant MW, Clark L, Sutton ET. (1999). Animal model of vascular inflammation. J Submicrosc Cytol Pathol 31:305-311.
33. Rhodin J, Thomas T, Bryant MW, Sutton ET. (2000). Animal model of Alzheimer-like vascular pathology and inflammatory reaction. Vascular factors in alzheimer's disease. Ann NY Acad Sci 903:345-352.
34. Roher AE. (1993). β-amyloid (1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer's disease. Proc Natl Acad Sci USA 90:10836-10840.
35. Sheng JG, Ito K, Skinner RD, Mark RE, Rovuaghi CR. Van Eldik LJ, Griffin ST. (1996). In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogeriesis. Neurobiol Aging 17:761-766.
36. Shibata M., Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV. (2000). Clearance of Alzheimer's amyloid-β 1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106:1489-1499.
37. Shimohama S, Tanino H, Kawakami N, Okamura N, Kodama H, Yamaguchi T, Hayakawa T, Nunomura N, Chiba S, Perry G, Smith MA, Fujimoto S. (2000). Activation of NADPH oxidase in Alzheimer's disease brains. Biochem Biophys Res Commun 273:5-9.
38. Shinkai Y, Yoshimura M, Ito Y, Odaka A, Suzuki N, Yanagisawa K, Ihara Y. (1995). Amyloid beta-proteins 1-40 and 1-42 (43) in the soluble fraction of extra-and intracranial blood vessels. Ann Neurol 38: 421-448.
39. Smith CCT. (1997). Stimulated release of the β-amyloid protein of Alzheimer's disease by normal human platelets. Neurosci. Lett. 235:157-159.
40. Sparks DL. (1997). Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Ann NY Acad Sci 826:128-146.
41. Sparks DL. (1999). Vascular related and mediated alterations in Alzheimer's disease. Cereb Cortex 14:733-772.
42. Stewart PA, Hayakawa K, Akers MA, Vinters HV. (1992). A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab Invest 67:734-742.
43. Strazielle N, Ghersi-Egea J-F, Ghiso J, Dehouck M-P, Frangione B, Patlak C, Fenstermacher J, Gorevic P. (2000). In vitro evidence that β-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability. J Neuropath Exp Neurol 59:29-38.
44. Sutton ET, Hellerman GR, Thomas T. (1997). β-amyloid induced endothelial necrosis and inhibition of nitric oxide production. Exp Cell Res 230:368-376.
45. Sutton ET, Thomas T, Bryant MW, Landon CS, Newton CA, Rhodiri JAG. (1999). Amyloid-β peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1. J Submicrosc Cytol Pathol 31:313-323.
46. Tanzi, RE. (1989). Molecular genetics of Alzheimer's disease and the amyloid-β peptide precursor gene. Ann Med 21:91-94.
47. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. (1996). β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380:168-171.
48. Thomas T, Sutton ET, Bryant MW, Rhodin JAG. (1997). In vivo vascular damage, leukocyte activation and inflammatory response induced by β-amyloid. J Submicrosc Cytol Pathol 29:293-304.
49. Thomas T, McLendon C, Sutton ET, Thomas G. (1997). Cerebrovascular endothelial dysfunction mediated by β-amyloid. NeuroReport 8:1387-1391.
50. Thomas T, Rhodin JAG, Sutton ET, Bryant MW, Price JM. (1999). Estrogen protects peripheral and cerebral blood vessels from toxicity of Alzheimer peptide amyloid-β and inflammatory reaction. J Submicrosc Cytol Pathol 31:571-579.
51. Thomas T, Rhodin J. (2000). Vascular actions of estrogens and Alzheimer s disease. Vascular factors in Alzheimer's disease. Ann NY Acad Sci 903:501-509.
52. Thomas T, Bryant MW, Clark L, Garces A, Rhodin J. (2001). Estrogen and raloxifene activities on amyloid-β induced inflammatory reaction. Microvasc Res 61:28-39.
53. Torreilles F, Salman-Tabcheh S, Gur-eacute;rin M-C, Torreilles J. (1999). Neurodegenerative disorders: the role of peroxynitrite. Brain Res Rev 30:153-163.
54. van Dyke K. (1997). The possible role of peroxynitrite in Alzheimer's disease: a simple hypothesis that could be tested more thoroughly. Med Hypotheses 48: 375-380.
55. Vinters HV, Pardridge WM. (1986). The blood-brain barrier in Alzheimer's disease. Can J Neurol Sci 13: 446-448.
56. Vinters HV. (1987). Cerebral amyloid angiopathy. A critical review. Stroke 18:311-324.
57. Vinters HV, Secor DL. Read SL, Frazee JG. Tomiyasu U, Stanley TM, Ferreiro JA, Akers MA. (1994). Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: an immunohistochemical and ultrastructural study. Ultrastruct Pathol 18:333-348.
58. Weller RO, Massey A. Newman TA, Hutchings M, Kuo Y-M, Roher AE. (1998). Cerebral amyloid angiopathy: β-amyloid accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 153:725-734.
59. Weller RO, Massey A, Kuo Y-M, Roher AE. (2000). Cerebral amyloid angiopathy: accumulation of Ab in interstitial fluid drainage pathways in Alzheimer s disease. Ann NY Acad Sci 903:110-117.
60. Wisniewski HM, Kozlowski PB. (1982). Evidence for blood-brain barrier changes in senile dementia of the Alzheimer type (SDAT). Ann NY Acad Sci 396:119-129.
61. Wisniewski HM, Wegiel J, Wang KC, Lach B. (1992). Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol 84:117-127.
62. Yamashita K, Miyakawa T, Katsuragi S. (1991). Vascular changes in brains with Alzheimer's disease. Jpn J Psychiatry Neural 45:79-84.
63. Van DS, Chen X, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM. (1996). RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691.
64. Zweifach BW. (1954). Direct observation of the mesenteric circulation in experimental animals. Anat Rec 120:277-288.